US OptionsDetailed Quotes

MRSN250117C7500

Watchlist

0.05
0.000.00%

15min DelayClose Jan 13 16:00 ET

0.00High0.00Low

Mersana Therapeutics Stock Discussion

70844100

Jan 10 15:10

Dilution 🥹

$Mersana Therapeutics (MRSN.US)$

LuckyLuke

Jan 10 14:42

$Mullen Automotive (MULN.US)$ racing with $Mersana Therapeutics (MRSN.US)$

Wins333

Jan 10 11:36

$Mersana Therapeutics (MRSN.US)$ I think 0.81 is in the safe zone

joeyboulevard

Jan 10 10:00

$Mersana Therapeutics (MRSN.US)$ .9 lfg

JN learn to trade

Jan 10 09:24

$Mersana Therapeutics (MRSN.US)$ why it keeps dropping ….

WeiTheSaint469

Jan 10 09:22

I bought in thats why it dropped

$Mersana Therapeutics (MRSN.US)$

flabbyduck

Jan 10 09:20

looking at this makes me sad $Mersana Therapeutics (MRSN.US)$

102270875

Jan 10 06:32

whats with the selloff here? isnt this news really good?

$Mersana Therapeutics (MRSN.US)$

Trytosaveabit

Jan 10 05:07

Update

$Mersana Therapeutics (MRSN.US)$ Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
GlobeNewswire· 4 mins ago
Conference call to discuss positive initial Phase 1 clinical data today at 8:30 a.m. ET

Jaguar8

Jan 10 05:06

ADDED NEWS

$Mersana Therapeutics (MRSN.US)$
Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
Friday, 10th January at 6:02 am
CAMBRIDGE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the U.S. Food and Drug...

No comment yet